Oxygen-ozone therapy as adjuvant in the current emergency in SARS-COV-2 infection: a clinical study.

Authors
Category Primary study
JournalJournal of biological regulators and homeostatic agents
Year 2020
The aim of the multicentre study promoted by Nuova FIO is to evaluate the beneficial effects of the systemic Oxygen-Ozone (O2O3) therapy in patients suffering from SARS COV-2 disease in the early phases of the disease, before worsening, up to the need of tracheal intubation. The study is based on the rationale on that the systemic oxygen-ozone treatment could be effective, positively influencing the disease evolution and/or being able to mitigate the onset of the cytokine storm syndrome at least partially.
Epistemonikos ID: dfb7e7163422f4c3e5616ea67b96daf0beefdb1c
First added on: May 29, 2020